Skip to content

Citius Oncology, Inc. CTOR IP Ramp D Milestones Included In License Payable

IP Ramp D Milestones Included In License Payable at other companies

Celcuity logo
CelcuityCELC
$5M
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$3.13M
Organon logo
OrganonOGN
$0-100%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$20M
RFL
Rafael Holdings, Inc.RFL
$4M0.0%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$17.5M

Other financials

Income statement

See full
Revenue$1.7M
Gross profit$1.3M
Operating income-$28.6M-283%
Net income-$26.6M-244%
EPS (diluted)-$0.27-145%

Balance sheet

See full
Cash & equivalents$2.6M+2,350,466%
Total equity$35.3M-1.0%
Total assets$100.7M+10.1%

Cash flow

See full
Operating cash flow-$3.8M-179%

Valuation

See full
Market cap$60.45M-74.7%

Returns & leverage

See full
Return on equity-119.9%+46.7pp
Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept ctor:IPRampDMilestonesIncludedInLicensePayable.

The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s ip ramp d milestones included in license payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Citius Oncology, Inc.'s IP ramp d milestones included in license payable?
Citius Oncology, Inc. (CTOR) reported IP ramp d milestones included in license payable of $7.1M in Q3 2024.
What does IP ramp d milestones included in license payable mean?
Represents the accrued or committed financial obligations related to research and development milestones for licensed intellectual property. It serves as a key indicator of future cash outflows required to maintain rights to critical development assets.